THOMAS TAYLOR to Survival Analysis
This is a "connection" page, showing publications THOMAS TAYLOR has written about Survival Analysis.
Connection Strength
0.045
-
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025 Dec; 21(1):2556591.
Score: 0.045